China Pioneer Pharma (CRPNF) 0.2260 $CRPNF
China Pioneer Pharma Announces Annual Results for Year Ended 31 December 2015
JCN Newswire - Wed Mar 30, 12:57AM CDT
HONG KONG, Mar 30, 2016 - (ACN Newswire) - China Pioneer Pharma Holdings Limited ("China Pioneer Pharma" or the "Company" or the "Group"; stock code: 01345), one of the largest comprehensive marketing, promotion and channel management service providers dedicated to imported pharmaceutical products and medical devices in China, today announced its annual results for the year ended 31 December 2015 (the "Year under Review"
.
Unity Balloon Expandable Bioresorbable Hybrid Biliary/Peripheral Vascular Stent Implanted for the 1st Time in Southeast Asia; China Pioneer Pharma is the distributor
JCN Newswire - Thu Mar 10, 5:51AM CST
China Pioneer Pharma Offers Free NeutroPhase to Victims Suffered Burns in the Explosion in Tianjin
JCN Newswire - Fri Aug 14, 3:21AM CDT
China Pioneer Pharma Holdings Limited, China's marketing, promotion and channel management service provider dedicated to imported pharmaceutical products and medical devices in China announces that it is going to offer free wound dressing liquid cleaning medical equipment product NeutroPhase to hospitals in order to help victims who suffered level one, level two and level three burns in the explosion in Tanggu, Binhai new area, Tianjin. China Pioneer Pharma will provide medical assistance to enhance the clinical treatment of burns and help the wound healing of serious patients and avoid the risk of fatal infections to save their lives. The hospitals include Tianjin Teda Hospital, Tianjin Fifth Centre Hospital,Tanggu Hospital of TCM, Tianjin fourth Hospital(Burn Department), Tianjin First Centre Hospital, Wujing Hospital, Tianjin Port Hospital.
China Pioneer Pharma Invited American Wound Care Expert to Provide Medical Advices for the Burn Victims in Taiwan's Dust Explosion
JCN Newswire - Fri Jul 10, 5:58PM CDT
China Pioneer Pharma Holdings Limited, China's marketing, promotion and channel management service provider dedicated to imported pharmaceutical products and medical devices in China, invited Dr. John Crew, a wound care expert from Seton Medical Center of the US and other expert team to visit victims who suffered burns in the dust explosion in Taiwan, and share with the patients the use of NeutroPhase for the treatment of deep 2nd grade & 3rd grade burns in order to exert the effect of NeutroPhase to the best. Recently, Dr John Crew has already visited National Taiwan University Hospital, Taipei Veterans General Hospital, Mackay Memorial Hospital and Tri-Service General Hospital and delivered his sincere blessings to the patients. As the exclusive distributor for NeutroPhase in mainland China, Taiwan and throughout Southeast Asia, China Pioneer Pharma has provided free NeutroPhase products and related medical advices for the burn victims, promoted more wide usage of NeutroPhase in Taiwan hospitals and help the treatment of burns to avoid deadly wound infection.
China Pioneer Pharma Offers Free NeutroPhase to Victims Suffered Burns in the Dust Explosion in Taiwan
JCN Newswire - Mon Jun 29, 8:48AM CDT
China Pioneer Pharma Holdings Limited, China's marketing, promotion and channel management service provider dedicated to imported pharmaceutical products and medical devices in China announces that it is going to offer free wound dressing liquid cleaning medical equipment product NeutroPhase and appropriate medical guidance to victims who suffered level one, level two and level three burns in the dust explosion in Taiwan. China Pioneer Pharma will provide medical assistance to enhance the clinical treatment of burns and help the wound healing of serious patients and avoid the risk of fatal infections to save their lives. The hospitals include Tri-Service General Hospital, Mackay Memorial Hospital, Taoyuan General Hospital, MOHW have put the medical devices NeutroPhase into use for free. The Company has also been contacting Shin Kong Wu Ho-Su Memorial Hospital, Taipei Medical University Hospital, Taipei City Hospital, Taichung Veterans General Hospital and other hospitals.
NeutroPhase Was Named as the Official Wound Cleanser of the NNFF
JCN Newswire - Wed Apr 01, 6:02AM CDT
China Pioneer Pharma Holdings Limited, one of the largest comprehensive marketing, promotion and channel management service providers dedicated to imported pharmaceutical products and medical devices in China, is pleased to announce that NeutroPhase, a skin and wound cleanser exclusively marketed, promoted and distributed by the Group in mainland China and parts of Southeast Asia, was recently named as the official wound cleanser of the National Necrotizing Fasciitis Foundation (NNFF) in the United States. The Group has already teamed up with NNFF and the product manufacturer - NovaBay Pharmaceuticals, Inc. to offer NeutroPhase and relevant medical guidance at no charge to patients who suffer from flesh-eating disease in the region in order to enable doctors to save life of patients as quick as possible and to curb the deterioration of the situation to avoid the need for amputation.
China Pioneer Pharma Joins Hand with NovaBay Pharmaceuticals and the NNFF To Offer Free New Life-Saving Treatment for "Flesh-Eating" Disease
JCN Newswire - Tue Dec 16, 5:51AM CST
China Pioneer Pharma Holdings Limited announces that, as the exclusive marketer, promotor and distributor for skin and wound cleanser NeutroPhase in mainland China and parts of Southeast Asia, the Group will offer the life- and limb-saving product, NeutroPhase, and relevant medical guidance at no charge to patients who suffer from flesh-eating disease in the region to tie in with the agreement signed between the product manufacturer - NovaBay Pharmaceuticals, Inc. and the National Necrotizing Fasciitis Foundation (NNFF) in the United States. This will enable doctors to save life of patients as quick as possible--- and to curb the deterioration of the situation to avoid the need for amputation.
China Pioneer Pharma was Granted Exclusive Importation, Sales and Co-Promotion Rights in Respect of Neoton
JCN Newswire - Tue Dec 02, 6:46AM CST
China Pioneer Pharma Holdings Limited announced that the Group through its wholly-owned subsidiary signed an agreement, with its important long-term partner Alfa Wassermann S.p.A of Italy for its product of creatine phosphate sodium for injection ("Neoton" on 2 December, 2014. According to the Agreement, the Group through its wholly-owned subsidiary was granted by Alfa Wassermann the exclusive importation, sales and co-promotion rights of Neoton in the People's Republic of China (excluding Hong Kong, Macao Special Administrative Region and Taiwan). The term of the Agreement shall start from today until 31 December, 2019.
China Pioneer Pharma Expands NeutroPhase Marketing in Taiwan
JCN Newswire - Tue Nov 04, 6:40PM CST
China Pioneer Pharma Holdings Limited, the leading comprehensive marketing, promotion and channel management service providers dedicated to imported pharmaceutical products and medical devices in China, today announced Taiwan's Food and Drug Administration has approved the launch of NovaBay Pharmaceuticals, Inc.'s medical devices product NeutroPhase Skin and Wound Cleanser for sale in Taiwan. China Pioneer Pharma will launch NeutroPhase in Taiwan in early 2015. NeutroPhase previously has been approved for sale throughout mainland China, Singapore, Malaysia and the United States. China Pioneer Pharma owns about 15% of NovaBay's shares, making it NovaBay's largest shareholder, and is also the exclusive distributor for NeutroPhase in mainland China and throughout Southeast Asia.
China Pioneer Pharma Announces Annual Results for Year Ended 31 December 2015
JCN Newswire - Wed Mar 30, 12:57AM CDT
HONG KONG, Mar 30, 2016 - (ACN Newswire) - China Pioneer Pharma Holdings Limited ("China Pioneer Pharma" or the "Company" or the "Group"; stock code: 01345), one of the largest comprehensive marketing, promotion and channel management service providers dedicated to imported pharmaceutical products and medical devices in China, today announced its annual results for the year ended 31 December 2015 (the "Year under Review"
. Unity Balloon Expandable Bioresorbable Hybrid Biliary/Peripheral Vascular Stent Implanted for the 1st Time in Southeast Asia; China Pioneer Pharma is the distributor
JCN Newswire - Thu Mar 10, 5:51AM CST
China Pioneer Pharma Offers Free NeutroPhase to Victims Suffered Burns in the Explosion in Tianjin
JCN Newswire - Fri Aug 14, 3:21AM CDT
China Pioneer Pharma Holdings Limited, China's marketing, promotion and channel management service provider dedicated to imported pharmaceutical products and medical devices in China announces that it is going to offer free wound dressing liquid cleaning medical equipment product NeutroPhase to hospitals in order to help victims who suffered level one, level two and level three burns in the explosion in Tanggu, Binhai new area, Tianjin. China Pioneer Pharma will provide medical assistance to enhance the clinical treatment of burns and help the wound healing of serious patients and avoid the risk of fatal infections to save their lives. The hospitals include Tianjin Teda Hospital, Tianjin Fifth Centre Hospital,Tanggu Hospital of TCM, Tianjin fourth Hospital(Burn Department), Tianjin First Centre Hospital, Wujing Hospital, Tianjin Port Hospital.
China Pioneer Pharma Invited American Wound Care Expert to Provide Medical Advices for the Burn Victims in Taiwan's Dust Explosion
JCN Newswire - Fri Jul 10, 5:58PM CDT
China Pioneer Pharma Holdings Limited, China's marketing, promotion and channel management service provider dedicated to imported pharmaceutical products and medical devices in China, invited Dr. John Crew, a wound care expert from Seton Medical Center of the US and other expert team to visit victims who suffered burns in the dust explosion in Taiwan, and share with the patients the use of NeutroPhase for the treatment of deep 2nd grade & 3rd grade burns in order to exert the effect of NeutroPhase to the best. Recently, Dr John Crew has already visited National Taiwan University Hospital, Taipei Veterans General Hospital, Mackay Memorial Hospital and Tri-Service General Hospital and delivered his sincere blessings to the patients. As the exclusive distributor for NeutroPhase in mainland China, Taiwan and throughout Southeast Asia, China Pioneer Pharma has provided free NeutroPhase products and related medical advices for the burn victims, promoted more wide usage of NeutroPhase in Taiwan hospitals and help the treatment of burns to avoid deadly wound infection.
China Pioneer Pharma Offers Free NeutroPhase to Victims Suffered Burns in the Dust Explosion in Taiwan
JCN Newswire - Mon Jun 29, 8:48AM CDT
China Pioneer Pharma Holdings Limited, China's marketing, promotion and channel management service provider dedicated to imported pharmaceutical products and medical devices in China announces that it is going to offer free wound dressing liquid cleaning medical equipment product NeutroPhase and appropriate medical guidance to victims who suffered level one, level two and level three burns in the dust explosion in Taiwan. China Pioneer Pharma will provide medical assistance to enhance the clinical treatment of burns and help the wound healing of serious patients and avoid the risk of fatal infections to save their lives. The hospitals include Tri-Service General Hospital, Mackay Memorial Hospital, Taoyuan General Hospital, MOHW have put the medical devices NeutroPhase into use for free. The Company has also been contacting Shin Kong Wu Ho-Su Memorial Hospital, Taipei Medical University Hospital, Taipei City Hospital, Taichung Veterans General Hospital and other hospitals.
NeutroPhase Was Named as the Official Wound Cleanser of the NNFF
JCN Newswire - Wed Apr 01, 6:02AM CDT
China Pioneer Pharma Holdings Limited, one of the largest comprehensive marketing, promotion and channel management service providers dedicated to imported pharmaceutical products and medical devices in China, is pleased to announce that NeutroPhase, a skin and wound cleanser exclusively marketed, promoted and distributed by the Group in mainland China and parts of Southeast Asia, was recently named as the official wound cleanser of the National Necrotizing Fasciitis Foundation (NNFF) in the United States. The Group has already teamed up with NNFF and the product manufacturer - NovaBay Pharmaceuticals, Inc. to offer NeutroPhase and relevant medical guidance at no charge to patients who suffer from flesh-eating disease in the region in order to enable doctors to save life of patients as quick as possible and to curb the deterioration of the situation to avoid the need for amputation.
China Pioneer Pharma Joins Hand with NovaBay Pharmaceuticals and the NNFF To Offer Free New Life-Saving Treatment for "Flesh-Eating" Disease
JCN Newswire - Tue Dec 16, 5:51AM CST
China Pioneer Pharma Holdings Limited announces that, as the exclusive marketer, promotor and distributor for skin and wound cleanser NeutroPhase in mainland China and parts of Southeast Asia, the Group will offer the life- and limb-saving product, NeutroPhase, and relevant medical guidance at no charge to patients who suffer from flesh-eating disease in the region to tie in with the agreement signed between the product manufacturer - NovaBay Pharmaceuticals, Inc. and the National Necrotizing Fasciitis Foundation (NNFF) in the United States. This will enable doctors to save life of patients as quick as possible--- and to curb the deterioration of the situation to avoid the need for amputation.
China Pioneer Pharma was Granted Exclusive Importation, Sales and Co-Promotion Rights in Respect of Neoton
JCN Newswire - Tue Dec 02, 6:46AM CST
China Pioneer Pharma Holdings Limited announced that the Group through its wholly-owned subsidiary signed an agreement, with its important long-term partner Alfa Wassermann S.p.A of Italy for its product of creatine phosphate sodium for injection ("Neoton"
on 2 December, 2014. According to the Agreement, the Group through its wholly-owned subsidiary was granted by Alfa Wassermann the exclusive importation, sales and co-promotion rights of Neoton in the People's Republic of China (excluding Hong Kong, Macao Special Administrative Region and Taiwan). The term of the Agreement shall start from today until 31 December, 2019. China Pioneer Pharma Expands NeutroPhase Marketing in Taiwan
JCN Newswire - Tue Nov 04, 6:40PM CST
China Pioneer Pharma Holdings Limited, the leading comprehensive marketing, promotion and channel management service providers dedicated to imported pharmaceutical products and medical devices in China, today announced Taiwan's Food and Drug Administration has approved the launch of NovaBay Pharmaceuticals, Inc.'s medical devices product NeutroPhase Skin and Wound Cleanser for sale in Taiwan. China Pioneer Pharma will launch NeutroPhase in Taiwan in early 2015. NeutroPhase previously has been approved for sale throughout mainland China, Singapore, Malaysia and the United States. China Pioneer Pharma owns about 15% of NovaBay's shares, making it NovaBay's largest shareholder, and is also the exclusive distributor for NeutroPhase in mainland China and throughout Southeast Asia.
